797 related articles for article (PubMed ID: 21266549)
1. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
Gooren LJ; Giltay EJ; Bunck MC
J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
[TBL] [Abstract][Full Text] [Related]
3. Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
van Kesteren PJ; Asscheman H; Megens JA; Gooren LJ
Clin Endocrinol (Oxf); 1997 Sep; 47(3):337-42. PubMed ID: 9373456
[TBL] [Abstract][Full Text] [Related]
4. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
Toorians AW; Thomassen MC; Zweegman S; Magdeleyns EJ; Tans G; Gooren LJ; Rosing J
J Clin Endocrinol Metab; 2003 Dec; 88(12):5723-9. PubMed ID: 14671159
[TBL] [Abstract][Full Text] [Related]
5. Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
Asscheman H; Gooren LJ; Eklund PL
Metabolism; 1989 Sep; 38(9):869-73. PubMed ID: 2528051
[TBL] [Abstract][Full Text] [Related]
6. Cross-sex hormone administration changes pain in transsexual women and men.
Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals.
Bunck MC; Giltay EJ; Diamant M; Gooren LJ; Teerlink T
Atherosclerosis; 2009 Sep; 206(1):245-50. PubMed ID: 19324362
[TBL] [Abstract][Full Text] [Related]
8. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.
Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ
J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351
[TBL] [Abstract][Full Text] [Related]
9. Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals.
Ott J; Aust S; Promberger R; Huber JC; Kaufmann U
J Sex Med; 2011 Aug; 8(8):2361-9. PubMed ID: 21595834
[TBL] [Abstract][Full Text] [Related]
10. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
[TBL] [Abstract][Full Text] [Related]
11. Hormone treatment of the adult transsexual patient.
Gooren L
Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
[TBL] [Abstract][Full Text] [Related]
12. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals.
Elbers JM; Asscheman H; Seidell JC; Gooren LJ
Am J Physiol; 1999 Feb; 276(2):E317-25. PubMed ID: 9950792
[TBL] [Abstract][Full Text] [Related]
13. [Morbidity in transsexual patients with cross-gender hormone self-treatment].
Becerra Fernández A; de Luis Román DA; Piédrola Maroto G
Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171
[TBL] [Abstract][Full Text] [Related]
14. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.
Giltay EJ; Hoogeveen EK; Elbers JM; Gooren LJ; Asscheman H; Stehouwer CD
J Clin Endocrinol Metab; 1998 Feb; 83(2):550-3. PubMed ID: 9467573
[TBL] [Abstract][Full Text] [Related]
15. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment.
Gooren LJ; van Trotsenburg MA; Giltay EJ; van Diest PJ
J Sex Med; 2013 Dec; 10(12):3129-34. PubMed ID: 24010586
[TBL] [Abstract][Full Text] [Related]
17. Sexual functioning in transsexuals following hormone therapy and genital surgery: a review.
Klein C; Gorzalka BB
J Sex Med; 2009 Nov; 6(11):2922-39; quiz 2940-1. PubMed ID: 20092545
[TBL] [Abstract][Full Text] [Related]
18. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity.
Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM
J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918
[TBL] [Abstract][Full Text] [Related]
19. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.
Mueller A; Gooren L
Eur J Endocrinol; 2008 Sep; 159(3):197-202. PubMed ID: 18567667
[TBL] [Abstract][Full Text] [Related]
20. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals.
Slabbekoorn D; van Goozen SH; Megens J; Gooren LJ; Cohen-Kettenis PT
Psychoneuroendocrinology; 1999 May; 24(4):423-47. PubMed ID: 10341369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
